Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase 2A Evaluation of the Safety, Tolerability, Pharmacokinetics, Efficacy of Clofazimine (CFZ) in Cryptosporidiosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03341767
Recruitment Status : Terminated (Insufficient accrual rate)
First Posted : November 14, 2017
Last Update Posted : August 13, 2019
Sponsor:
Collaborators:
Bill and Melinda Gates Foundation
The Emmes Company, LLC
Calibr, a division of Scripps Research
Liverpool School of Tropical Medicine
University of Virginia
Malawi-Liverpool-Wellcome Trust Clinical Research Programme
Information provided by (Responsible Party):
Wes Van Voorhis, University of Washington